This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wedege, E. Articles by Caugant, D. A. Search for Related Content PubMed PubMed Citation Articles by Wedege, E. Articles by Caugant, D. A.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, 05 1995, 314-321, Vol 2, No. 3
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Emergence of a new virulent clone within the electrophoretic type 5 complex of serogroup B meningococci in Norway

E Wedege, J Kolberg, A Delvig, EA Hoiby, E Holten, E Rosenqvist and DA Caugant
Department of Vaccine, National Institute of Public Health, Oslo, Norway.

An increase in B:15:P1.12 meningococci among isolates from patients with Neisseria meningitidis infection in Norway in recent years led to further characterization of such strains. Between 1987 and 1992, B:15:P1.12 strains constituted 9.8% (24 strains) of B:15 isolates. The B:15:P1.12 strains belonged to the electrophoretic type 5 (ET-5) complex, but 17 (71%) strains were a new clone (ET-5c) not found elsewhere in the world. All but one strain of ET-5c were responsible for a localized outbreak of systemic meningococcal disease in western Norway. A novel monoclonal antibody (202,G-12), developed against the unknown variable region 2 on the class 1 protein of one of these strains, bound to 19 of the 15:P1.12 strains, 4 strains bound the subtype P1.13 reference monoclonal antibody MN24H10.75, and the remaining strain showed no reaction. Sequencing of porA genes demonstrated a series of nine threonine residues in the deduced variable region 2 of the latter strain, while four and five threonine residues were found in the corresponding regions of strains reacting with the monoclonal antibodies 202,G-12 and MN24H10.75, respectively. Epitope mapping with synthetic peptides showed that 202,G-12 bound to a sequence of 11 amino acids which included the four threonine residues specific for subtype P1.13a. Immunoglobulin G antibodies against the P1.7,16 subtype protein, induced in volunteers after vaccination with the Norwegian meningococcal vaccine, did not cross-react on immunoblots with the subtype protein of clone ET-5c. Thus, postvaccination class 1 protein antibodies, assumed to be protective, may not be effective against infection with the new clone.

This article has been cited by other articles:

• Harrison, L. H. (2006). Prospects for Vaccine Prevention of Meningococcal Infection. Clin. Microbiol. Rev. 19: 142-164 [Abstract] [Full Text]  
• Urwin, R., Russell, J. E., Thompson, E. A. L., Holmes, E. C., Feavers, I. M., Maiden, M. C. J. (2004). Distribution of Surface Protein Variants among Hyperinvasive Meningococci: Implications for Vaccine Design. Infect. Immun. 72: 5955-5962 [Abstract] [Full Text]  
• Shlush, L. I., Behar, D. M., Zelazny, A., Keller, N., Lupski, J. R., Beaudet, A. L., Bercovich, D. (2002). Molecular Epidemiological Analysis of the Changing Nature of a Meningococcal Outbreak following a Vaccination Campaign. J. Clin. Microbiol. 40: 3565-3571 [Abstract] [Full Text]  
• Kyaw, M. H., Clarke, S. C., Christie, P., Jones, I. G., Campbell, H. (2002). Invasive Meningococcal Disease in Scotland, 1994 to 1999, with Emphasis on Group B Meningococcal Disease. J. Clin. Microbiol. 40: 1834-1837 [Abstract] [Full Text]  
• Rokbi, B., Renauld-Mongenie, G., Mignon, M., Danve, B., Poncet, D., Chabanel, C., Caugant, D. A., Quentin-Millet, M.-J. (2000). Allelic Diversity of the Two Transferrin Binding Protein B Gene Isotypes among a Collection of Neisseria meningitidis Strains Representative of Serogroup B Disease: Implication for the Composition of a Recombinant TbpB-Based Vaccine. Infect. Immun. 68: 4938-4947 [Abstract] [Full Text]  
• Bygraves, J. A., Urwin, R., Fox, A. J., Gray, S. J., Russell, J. E., Feavers, I. M., Maiden, M. C. J. (1999). Population Genetic and Evolutionary Approaches to Analysis of Neisseria meningitidis Isolates Belonging to the ET-5 Complex. J. Bacteriol. 181: 5551-5556 [Abstract] [Full Text]  
• Sacchi, C. T., Lemos, A. P. S., Brandt, M. E., Whitney, A. M., Melles, C. E. A., Solari, C. A., Frasch, C. E., Mayer, L. W. (1998). Proposed Standardization of Neisseria meningitidis PorA Variable-Region Typing Nomenclature. CVI 5: 845-855 [Abstract] [Full Text]  
• Van Looveren, M., Vandamme, P., Hauchecorne, M., Wijdooghe, M., Carion, F., Caugant, D. A., Goossens, H. (1998). Molecular Epidemiology of Recent Belgian Isolates of Neisseria meningitidis Serogroup B. J. Clin. Microbiol. 36: 2828-2834 [Abstract] [Full Text]  
• Wedege, E., Hoiby, E. A., Rosenqvist, E., Bjune, G. (1998). Immune Responses against Major Outer Membrane Antigens of Neisseria meningitidis in Vaccinees and Controls Who Contracted Meningococcal Disease during the Norwegian Serogroup B Protection Trial. Infect. Immun. 66: 3223-3231 [Abstract] [Full Text]  
• Sacchi, C. T., Lemos, A. P. S., Whitney, A. M., Solari, C. A., Brandt, M. E., Melles, C. E. A., Frasch, C. E., Mayer, L. W. (1998). . CVI 5: 348-354 [Abstract]